Carlyle: Travelers CEO steps off board to fight illness - 10/28/2015

Share on Facebook

Share on Twitter

Share on LinkedIn

In the Margins

Carlyle: Travelers CEO steps off board to fight illness

October 28, 2015

By Bloomberg

Carlyle Group LP said Travelers Cos. CEO Jay Fishman stepped down from its board while fighting amyotrophic lateral sclerosis, or ALS. Fishman, 62, said in August he would be replaced as Travelers CEO on Dec. 1 by Alan Schnitzer and stay on as executive chairman. Anthony Welters, executive chairman of investment company Black Ivy Group and a senior adviser to the office of the CEO at UnitedHealth Group Inc., has joined the Carlyle board as independent director. Read the original story from Bloomberg.

Most Read

A Seat at the Table
IDC, MFDF team up to move board diversity convo forward

In two weeks' time, independent mutual fund directors will gather in New York to discuss issues related board composition and diversity in the boardroom. The directors—and ...

Top of the Agenda - Industry Groups
ICI's Pan rails against 'over-regulation,' warns of costs, consequences

Investment Company Institute CEO Eric Pan came out swinging on Tuesday, delivering keynote remarks to 2024 Investment Management Conference attendees in which he railed against "over-regulation" and vowed ...

Top of the Agenda - Regulatory
SEC official suggests swing pricing is dead for open-end funds

A senior member of the Securities and Exchange Commission's Division of Investment Management on Monday indicated to mutual fund industry professionals that the Commission will not ...

10 Things
10 Women...making a difference in the boardroom and beyond

Today is International Women's Day, and there's plenty to celebrate in the mutual fund governance space. Women have made strides in recent years in getting into ...